Anesthesia Management of Coronary Artery Bypass Surgery and Inflammatory Biomarkers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

228 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-08

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate effect of total intravenous anesthesia or inhalation anesthesia on inflammatory biomarkers in coronary artery bypass surgery and their relationship with early postoperative complications. The main questions it aims to answer are

* Does the type of anesthesia have a relationship with inflammatory biomarkers?
* Are inflammatory biomarkers associated with postoperative complications?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

TIVA Versus Inhalational Anesthesia and Tissue Oxygenation in Cardiac Surgery

NCT05320341

Cardiac Anesthesia

COMPLETED

Comparison of Airway Management With Bronchial Blocker and Double-Lumen Tube in Single-Lung Ventilation

NCT06299735

Heart Valvular Disease Coronary Arteriosclerosis One-lung Ventilation

RECRUITING NA

Fast-Track in Cardiac Anesthesia

NCT05321173

Cardiac Surgery

COMPLETED

Low and Moderete Flow Anaesthesia on Haemodynamics

NCT06871371

Hemodynamics Instability Arrhythmias Cardiac Cerebral Oxygenation

NOT_YET_RECRUITING NA

Evaluation of Fluid Responsiveness With Recruitment Maneuver After Sternotomy in Coronary Artery Bypass Surgery

NCT06249568

Fluid Therapy Coronary Artery Bypass Surgery Patients Lung Recruitment Maneuver

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is planned to be a prospective observational clinical study. Patients who will undergo on-pump coronary artery bypass surgery, meet the eligibility criteria and agree to participate in the study and sign the informed patient consent form will be included in the study.Systemic immune inflammatory index, systemic inflammatory response index, neurophile lymphocyte ratio, platelet lymphocyte ratio will be calculated in the routine complete blood count of patients in the last 3 preoperative days and in the first 24 hours postoperatively.It will be evaluated whether these biomarkers are related to the anesthesia technique used, patients comorbidities and the complications that develop in the first 24 hours postoperatively. Patients will be evaluated preoperatively, intraoperatively and postoperatively; preoperative comorbidities, intraoperative anesthesia management, cross clamp, pump and surgery times, blood and blood product transfusion, inotrope use and complications that develop up to the first 24 hours postoperatively will be recorded.The anesthetic technique to be used will be determined according to the anesthesiologist's preference and will be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Postoperative Complications Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inhalation Anesthesia Group

After induction, anesthesia will be provided with sevoflurane (2.0 mac) and intravenous remifentanil infusion (0.05-0.2 mcg/kg/min). Depth of anesthesia will be evaluated with Bispectral Index (BIS).

No interventions assigned to this group

Total Intravenous Anesthesia Group

After induction, anesthesia will be provided with intravenous propofol infusion (50-150 mcg/kg/min) and intravenous remifentanil infusion (0.05-0.2 mcg/kg/min). Depth of anesthesia will be evaluated with Bispectral Index (BIS).

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* On-pump bypass surgery
* Del-Nido cardioplegia used in operation
* ASA (American Society of Anesthesiologists) II- III patients

Exclusion Criteria

* Patients with active malignancy
* Diagnosed with systemic inflammatory disease or autoimmune disease
* Chronic liver and kidney disease
* History of cerebrovascular disease within 6 months
* EF (Ejection Fraction) \< 45%
* Non-cooperative or patients who do not agree to participate in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No